Protara Therapeutics TARA
$ 2.38
3.97%
Quarterly report 2024-Q3
added 11-12-2024
Protara Therapeutics Cash Flow 2011-2024 | TARA
Annual Cash Flow Protara Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-37.6 M | -26.5 M | -34.5 M | -23.4 M | -5.01 M | -23.2 M | -22.4 M | -23.7 M | -17.6 M | - | - | - | - |
Depreciation & Amortization |
341 K | 248 K | 117 K | 103 K | 16 K | 115 K | 148 K | 123 K | 57 K | 30 K | 27 K | 57 K | - |
Accounts Payables |
2.43 M | 1.59 M | 954 K | 914 K | 263 K | 441 K | 291 K | 556 K | 1.02 M | 917 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Protara Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -10.4 M | - | - | - | -12.9 M | - | -21.4 M | -16.1 M | -11 M | - | -27.6 M | -21.4 M | -11.9 M | - | -16.6 M | -12.9 M | -7.15 M | - | -3.92 M | -2.71 M | -1.41 M | - | -18.9 M | -15.8 M | -5.46 M | - | -16.7 M | -10.7 M | -7.45 M | - | -18.1 M | - | - | - | - | - | - | - | - | - | - | - | -4.91 M | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 83 K | - | - | - | 77 K | - | 173 K | 109 K | 56 K | - | 63 K | 87 K | 32 K | - | 71 K | 44 K | 50 K | - | 100 K | 21 K | 174 K | - | 22 K | 29 K | 32 K | - | 115 K | 77 K | 40 K | - | 87 K | 52 K | 24 K | - | 33 K | 17 K | 8 K | - | 21 K | 13 K | 7 K | - | 21 K | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.3 M | 1.38 M | 972 K | 2.43 M | 2.5 M | 1.85 M | 4.08 M | 1.59 M | 456 K | 392 K | 541 K | 954 K | 928 K | 1.4 M | 1.85 M | 914 K | 914 K | 914 K | 914 K | 716 K | 716 K | 716 K | 716 K | 441 K | 441 K | 441 K | 441 K | 291 K | 291 K | 291 K | 291 K | 556 K | 556 K | 556 K | 556 K | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 917 K | 917 K | 917 K | 917 K | 399 K | 399 K | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency